Free Trial
FRA:FRE

Fresenius SE & Co. KGaA (FRE) Stock Price, News & Analysis

Fresenius SE & Co. KGaA logo
€39.01 -0.49 (-1.24%)
As of 04/17/2025

About Fresenius SE & Co. KGaA Stock (FRA:FRE)

Key Stats

Today's Range
€38.72
€39.56
50-Day Range
€35.17
€40.65
52-Week Range
€60.16
€80.00
Volume
928,953 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Receive FRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FRE Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

FRE Stock Analysis - Frequently Asked Questions

Fresenius SE & Co. KGaA's stock was trading at €33.48 at the start of the year. Since then, FRE stock has increased by 16.5% and is now trading at €39.01.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius SE & Co. KGaA investors own include Illumina (ILMN), Daimler (DAI), Endologix (ELGX), APA (APA), Cambrex (CBM), Micron Technology (MU) and Bayer Aktiengesellschaft (BAYN).

Industry, Sector and Symbol

Stock Exchange
FRA
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
Medical Equipment
Current Symbol
FRA:FRE
CIK
N/A
Fax
N/A
Employees
190,863
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (FRA:FRE) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners